Cargando…

Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice

Inflammatory bowel disease (IBD) comprises ulcerative colitis (UC) and Crohn’s disease (CD). IBD etiopathology is multifactorial and involves alteration of immune cells and chronic activation of the inflammatory cascade against yet unknown environmental factors that trigger the disease. IBD therapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bruscoli, Stefano, Febo, Marta, Riccardi, Carlo, Migliorati, Graziella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209469/ https://www.ncbi.nlm.nih.gov/pubmed/34149734 http://dx.doi.org/10.3389/fimmu.2021.691480

Ejemplares similares

Anti-Inflammatory Effects of Synthetic Peptides Based on Glucocorticoid-Induced Leucine Zipper (GILZ) Protein for the Treatment of Inflammatory Bowel Diseases (IBDs)
por: Paglialunga, Musetta, et al.
Publicado: (2023)

Glucocorticoid-Induced Leucine Zipper: A Novel Anti-inflammatory Molecule
por: Bereshchenko, Oxana, et al.
Publicado: (2019)

Glucocorticoid-Induced Leucine Zipper Inhibits Interferon-Gamma Production in B Cells and Suppresses Colitis in Mice
por: Bruscoli, Stefano, et al.
Publicado: (2018)

Role of histamine H(4) receptor in the anti-inflammatory pathway of glucocorticoid-induced leucin zipper (GILZ) in a model of lung fibrosis
por: Sgambellone, Silvia, et al.
Publicado: (2023)

Glucocorticoids, Sex Hormones, and Immunity
por: Bereshchenko, Oxana, et al.
Publicado: (2018)

A Glance at the Use of Glucocorticoids in Rare Inflammatory and Autoimmune Diseases: Still an Indispensable Pharmacological Tool?
por: Ronchetti, Simona, et al.
Publicado: (2021)

GILZ as a Mediator of the Anti-Inflammatory Effects of Glucocorticoids
por: Ronchetti, Simona, et al.
Publicado: (2015)

Transcriptional regulation of kinases downstream of the T cell receptor: another immunomodulatory mechanism of glucocorticoids
por: Petrillo, Maria Grazia, et al.
Publicado: (2014)

Glucocorticoid-induced leucine zipper (GILZ)/NF-κB interaction: role of GILZ homo-dimerization and C-terminal domain
por: Marco, Barbara Di, et al.
Publicado: (2007)

How Glucocorticoids Affect the Neutrophil Life
por: Ronchetti, Simona, et al.
Publicado: (2018)

Glucocorticoids and COVID-19
por: Bruscoli, Stefano, et al.
Publicado: (2022)

Amplified Host Defense by Toll-Like Receptor-Mediated Downregulation of the Glucocorticoid-Induced Leucine Zipper (GILZ) in Macrophages
por: Hoppstädter, Jessica, et al.
Publicado: (2019)

Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment
por: Flamini, Sara, et al.
Publicado: (2021)

Association of GILZ with MUC2, TLR2, and TLR4 in Inflammatory Bowel Disease
por: Cari, Luigi, et al.
Publicado: (2023)

Glucocorticoid Receptor-Deficient Foxp3(+) Regulatory T Cells Fail to Control Experimental Inflammatory Bowel Disease
por: Rocamora-Reverte, Lourdes, et al.
Publicado: (2019)

Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiovascular Health and Disease
por: Cappetta, Donato, et al.
Publicado: (2021)

Endothelial Response to Glucocorticoids in Inflammatory Diseases
por: Zielińska, Karolina A., et al.
Publicado: (2016)

Anti-Adhesion Therapies in Inflammatory Bowel Disease—Molecular and Clinical Aspects
por: Zundler, Sebastian, et al.
Publicado: (2017)

Inflammatory Bowel Disease Therapy: Beyond the Immunome
por: Fiocchi, Claudio, et al.
Publicado: (2022)

Glucocorticoid-Induced Leucine Zipper-Mediated TLR2 Downregulation Accounts for Reduced Neutrophil Activity Following Acute DEX Treatment
por: Ricci, Erika, et al.
Publicado: (2021)

Glucocorticoid-Induced Tumour Necrosis Factor Receptor-Related Protein: A Key Marker of Functional Regulatory T Cells
por: Ronchetti, Simona, et al.
Publicado: (2015)

Fighting the Fire: Mechanisms of Inflammatory Gene Regulation by the Glucocorticoid Receptor
por: Escoter-Torres, Laura, et al.
Publicado: (2019)

Implicating the Role of GILZ in Glucocorticoid Modulation of T-Cell Activation
por: Cannarile, Lorenza, et al.
Publicado: (2019)

Overexpression of Glucocorticoid-induced Leucine Zipper (GILZ) increases susceptibility to Imiquimod-induced psoriasis and involves cutaneous activation of TGF-β1
por: Carceller, Elena, et al.
Publicado: (2016)

Altered glucocorticoid metabolism represents a feature of macroph‐aging
por: Valbuena Perez, Jenny Vanessa, et al.
Publicado: (2020)

Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential
por: Xu, Qiuyun, et al.
Publicado: (2022)

Fatty acids and lipid mediators in inflammatory bowel disease: from mechanism to treatment
por: Yan, Dong, et al.
Publicado: (2023)

Identification and investigation of depression-related molecular subtypes in inflammatory bowel disease and the anti-inflammatory mechanisms of paroxetine
por: Ning, Lijun, et al.
Publicado: (2023)

Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy
por: Wang, Yifei, et al.
Publicado: (2022)

Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases
por: Che, Zhengping, et al.
Publicado: (2022)

GILZ as a Regulator of Cell Fate and Inflammation
por: Bruscoli, Stefano, et al.
Publicado: (2021)

Screening for adrenal suppression in children with inflammatory bowel disease discontinuing glucocorticoid therapy
por: Sidoroff, Marianne, et al.
Publicado: (2014)

Glucocorticoid Therapy of Multiple Sclerosis Patients Induces Anti-inflammatory Polarization and Increased Chemotaxis of Monocytes
por: Fischer, Henrike J., et al.
Publicado: (2019)

Cutaneous manifestations of inflammatory bowel disease: basic characteristics, therapy, and potential pathophysiological associations
por: He, Ronghua, et al.
Publicado: (2023)

Diversity of Intestinal Macrophages in Inflammatory Bowel Diseases
por: Kühl, Anja A., et al.
Publicado: (2015)

Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis
por: Loddo, Italia, et al.
Publicado: (2015)

Role of Incretin Axis in Inflammatory Bowel Disease
por: Duan, Lihua, et al.
Publicado: (2017)

Toll-like Receptors and Inflammatory Bowel Disease
por: Lu, Yue, et al.
Publicado: (2018)

NLRP3 Inflammasome and Inflammatory Bowel Disease
por: Zhen, Yu, et al.
Publicado: (2019)

The Role of Dietary Nutrients in Inflammatory Bowel Disease
por: Sugihara, Kohei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qikvaee6kdkqhuq9tef16030ik